Figure 1.

Based on Diabetic Retinopathy Clinical Research Network results,⁶ a. mean visual acuity change from baseline among 4 groups randomized to prompt focal/grid laser plus a sham intravitreal injection, prompt laser plus intravitreal ranibizumab, deferred laser (for at least 24 weeks) plus intravitreal ranibizumab, or prompt laser plus intravitreal corticosteroids through 2 years with a three year comparison of the two ranibizumab groups; b. fundus photograph of case with diabetic macular edema and lipid (circle), i.e., hard exudates, near the center of the macula.